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Abstract: Achieving the stable osteointegration of prosthetic implants is one of the great challenges of
modern orthopedic surgery. The fixation of ceramic acetabular cups of hip joint prostheses is usually
achieved using a metal shell provided with screws or pegs that penetrate into the host pelvic bone.
The deposition of bioactive coatings on the implant surface to be put in contact with bone could
be a valuable strategy to promote a more “physiological” osteointegration. In this work, bioactive
glass porous coatings were manufactured on the top of alumina/zirconia composite implants by
two different methods, i.e., sponge replication and laser cladding. The coated samples underwent
immersion studies in Kokubo’s simulated body fluid (SBF) to assess in vitro bioactivity and were
found to exhibit an excellent hydroxyapatite-forming ability, which is key to allow bonding to bone.
Biological tests using mesenchymal stem and osteoblast-like cells revealed the good biocompatibility
of both types of materials. Furthermore, a higher level of mineralization was induced by the
sponge-replicated coatings at 10 days. Overall, these results are highly promising and encourage
further research on these materials.
Keywords: bioceramics; bioactive glass; scaffold; in vitro; bioactivity; prosthesis; coating
1. Introduction
Prosthetic implants are of great importance nowadays due to the increase of the elderly population
worldwide with associated age-related musculoskeletal pathologies. In all of their forms and applications,
implantable materials can be used for many purposes, from healing assistance to the complete replacement
of human bones and joints in order to enhance the quality of living and healthy ageing [1].
The mechanical properties of the different materials used in bone prostheses must be sufficient
to comply with the structural conditions required once the prostheses are implanted in a person.
Ideally, the mechanical properties of the implant should be as similar as possible to those of host
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bone. The mechanical properties of bones depend on their density, which may significantly vary in
the skeleton, according to the main function they have to accomplish. There are estimations in the
literature of the Young’s modulus and strength for different kinds and parts of bones. The cortical
bones have a Young’s modulus in the range of 1–20 GPa and a strength in the range of 1–100 MPa [2].
The cancellous bones, being significantly more porous (up to 80% in vertebral bodies), have a Young’s
modulus in the range of 0.1–1.0 GPa and a maximum yield strength in the range of 1–10 MPa [3].
Metals, ceramics, and polymers can all be used to manufacture bone implants by different
production methods, which impose several constraints on the performance of the parts achieved [4].
Metal components are used in more than 70% of prosthetic implants [5]. Nevertheless, metallic
materials and their alloys have a high Young’s modulus and high maximum yield strength compared
to bone. The Young’s modulus of titanium, for example, is within 100–120 GPa [6], which causes a
mismatch with the stiffness of bone. Furthermore, metals can be susceptible to corrosion and wear
in vivo and cannot bond to living bone; these limitations can be mitigated by depositing coating
materials that have a protective effect and exhibit a more similar chemical composition and fine
microstructure to the bones, thereby promoting osteointegration. From a technological viewpoint,
depositing a ceramic layer on the surface of metallic implants is challenging due to the significant
mismatch between the thermal expansion coefficients of the materials involved, which leads to difficult
adhesion [7]. Good results were reported for plasma-sprayed hydroxyapatite coatings on metallic joint
prostheses in terms of bone-implant fixation, but there still are some concerns on the stability of these
coatings in the long term [8].
Polymers exhibit an excellent biocompatibility with cells and tissues, but typically suffer from
poor structural behavior. In the last years, polymers have been extensively investigated for bone-tissue
applications. Natural polymers are reported to have problems of structural instability due to
progressive resorption over time once implanted in vivo [9]. Synthetic polymers can overcome this
drawback and their properties can be finely tailored by acting on the composition and synthesis
process [10,11]. The Young’s modulus of biomedical polymers is typically in the range of 0.35 to
7 GPa [12], which better fits that of bone as compared to metals, but the strength often still remains
inadequate for load-bearing applications.
Ceramic-based prostheses open a wide opportunity window for achieving a better biomimetic
behavior than any other solution. Ceramic materials such as calcium phosphates, bioactive
glasses, alumina, and zirconia have been studied for medical applications for five decades [13].
Polymer–ceramic composites are further possible combinations for achieving biomedical materials
with finely tuned bioactive and mechanical properties [14]; however, these composites are only used
for non-load-bearing applications [15].
General methods for manufacturing ceramic-based prostheses include molding, additive
manufacturing, machining, or a combination of two or more of these processes, with heat treatments
in the form of oven sintering [16–19].
Alumina, zirconia, and composites thereof have been found to be highly suitable for fabricating
femur heads and ceramic inserts (acetabular cups) in hip joint prostheses due to their anti-friction
properties, high strength, and excellent biocompatibility in the body [20]. At present, ceramic acetabular
cups are fixed to the patient’s pelvic bone intraoperatively by using a metal shell, called “metal-back”.
This procedure can carry the risk of incorrect positioning of the implant (miscentering) and mechanical
damage to the host bone. The need for the metal-back and relevant disadvantages could be overcome
by the deposition of a bioactive coating on the outer surface of the acetabular cup for promoting
osteointegration [21].
This work is the third part of a trilogy focused on demonstrating the feasibility of the
above-mentioned approach, in which bioactive glasses are used to innovatively manufacture
multi-layered coatings mimicking the architecture of cancellous bone [22,23]. A scheme of this concept
is illustrated in Figure 1. A couple of previous studies reported the successful fabrication of trabecular
coatings on ceramic acetabular cups by sponge replication [14] and laser cladding [24]. The present
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work moves a step forward and aims at assessing the in vitro bioactivity (i.e., the HA-forming
capability in simulated body fluid) and biological compatibility of both types of coatings in a simplified
flat configuration.Int. J. Mol. Sci. 2018, 19, x 3 of 14 
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cancellous bone (Figure 2a). On the contrary, the surface pores of laser-cladded coatings are formed 
at the intersections of the fused glass tracks and as a result of PVA burn-off (Figure 2b). These 
morphological results, which are referring to flat coatings, are consistent with previous observations 
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Figure 1. Single-piece multi-layered acetabular component of the innovative hip joint prosthesis
proposed by the authors: the ceramic cup is coated by a bone-like porous layer of bioactive glass that is
potentially able to bond to the host bone.
2. Results and Discussion
The methods adopted for manufacturing the top porous layers on the alumina/zirconia composite
pellets, i.e., sponge replication and laser cladding, led to significantly different results, as illustrated in
Figure 2. The sponge replica method allows a 3D porous structure with large and open macropores
(100–500 µm) to be obtained, which closely mimics the trabecular architecture of cancellous bone
(Figure 2a). On the contrary, the surface pores of laser-cladded coatings are formed at the intersections
of the fused glass tracks and as a result of PVA burn-off (Figure 2b). These morphological results,
which are referring to flat coatings, are consistent with previous observations on a c rved geometry
(acetabular cup) [16–24].
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The final scope of the multi-layered prosthetic devices presented in this work is to stimulate bone
in-growth and regeneration, thus potentially allowing the direct attachment of the implant to the host
bone. As mentioned in the introduction, on the basis of robust experimental work carried out by many
research groups over the last three decades [25,26], it is assumed that the formation of a hydroxyapatite
(HA)-like layer on the surface of biomaterials in SBF is reliable proof of the capability to bond to living
bone in vivo. Therefore, the assessment of in vitro bioactivity of the glass coatings produced in this
work is of the utmost importance to support their medical suitability.
Following contact with a physiological fluid, the in vitro formation of HA on the surface of
bioactive glasses occurs through a sequence of five consecutive stages [27]:
1. Na+ cations are rapidly released and replaced by H+ ions from the solution;
2. the corresponding increase of local pH promotes the breaking of Si–O–Si bonds on the glass
surface and the release of soluble silica;
3. some of the surface Si–OH groups formed in steps (1) and (2) condense to form a hydrated
silica-rich layer on the glass surface, which is depleted of modifiers ions;
4. calcium and phosphate ions are released through the silica gel layer, which incorporates other
Ca2+ and (PO4)3− ions from the solution to form an amorphous calcium phosphate phase;
5. this amorphous film may incorporate additional carbonate ions from the solution and eventually
crystallize into hydroxycarbonate apatite.
Silicate glasses are characterized by a continuous network, fully interconnected in 3D, with every
silica tetrahedron linked by bridging oxygens (BOs) to four adjacent tetrahedra. The addition of alkali
or alkaline-earth metal cations (the so-called “modifiers”) breaks the silicate network by replacing
Si–BO–Si bonds with Si–NBO, where NBO is a non-bridging oxygen. Ionic bonds between NBOs
and modifiers ensure the local charge balance and the overall charge neutrality. Although being
weaker than the covalent Si–O bonds, the ionic interaction between NBOs and modifiers is extremely
important as far as glass reactivity is concerned [28]. The larger the number of NBOs in the glass
structure, the higher the solubility of small silica fragments in SBF; hence, a high degree of glass
network fragmentation is strongly correlated to the high bioactivity of the glass.
The results of in vitro bioactivity studies in SBF are shown in Figure 3. The SEM back-scattering
mode (Figure 3a) emphasized the presence of a newly-formed phase on the trabeculae of the S50B2
porous coating. Compositional analysis was performed by Energy Dispersive Spectroscopy (EDS).
EDS revealed that this new phase is rich in calcium and phosphorus, with a Ca-to-P atomic ratio of
1.2. This value is lower than the Ca-to-P ratio of stoichiometric HA (1.67) and indicates that, actually,
a Ca-deficient HA is formed on this material. This situation is quite common for the HA-like phase
formed on the surface of bioactive glasses, as observed in previous investigations on other silicate
glass compositions [29,30]. The surface morphology of this new phase, shown in Figure 3, exhibits
the typical “cauliflower” appearance of bone-like HA, formed by globular agglomerates in which
needle-like nanocrystals can be detected (Figure 3d).
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The presence of an HA-like layer on the struts of the porous coating is expected to play a key role
in promoting colonization by bone cells in vivo, as it was demonstrated that osteoblasts attach and
spread preferably on nanocrystalline HA due to its chemi al and crystallogr phic similarity to bone
mineral [31]. In this regard, th HA lay r can be interpreted as a “biomimetic skin” that continuously
and homogeneously covers all the surface of the porous coating (see Figure 3c). It is noteworthy that
the peak of silicon, which is indicative of the glass and/or silica el layer, is no more visible in the EDS
plot reported in Figure 3b.
Figure 3a also reveals the excell t j i i t t t l ( i s strate + interlayer
+ porous coating) that constitute the device. This confirms that the integrity of the implant is
retained after immersion is biological fluids, which is of crucial importance for the safety of any
clinical application.
The mechanical s itability of these materials for potential use in prosthetic and bone implant
applications was evaluat d in previous studies [16,32]. Tensile (pull-out) test all wed the authors
to determine that the adhesi n str ngth of S57A7 coatings on alumina was about 27 MP [16].
Interestingly, this value is two times higher t an that recommended by the ISO13779 standard for HA
coatings on surgical impl nts [33]. Therefor , th high onding strength of S57A7 coatings supports
their mecha ical uitability for the intended biomedic l pplication.
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The tensile strength of porous S50B2 samples was assessed to be in the range of 5.4 to 7.8 MPa.
This value is comparable to the tensile strength of bovine spongy bone (7.6 ± 2.2 MPa [34]) and human
trabecular bone (10–20 MPa [35]).
The biological compatibility of the multi-layered implants produced by sponge replication and
laser cladding was assessed by early cell seeding experiments. As shown in Figure 4; Figure 5, both cell
types attached and proliferated over time on all substrates, with moderate or no differences in terms of
cell count. The number of MSCs grown on the sponge-replicated coating at three days is lower than
that assessed on the laser-cladded implant. On the contrary, no statistically significant differences were
found at the same time point if the samples were seeded with Saos-2 cells. No statistically significant
differences were found at seven days for MSCs seeded on both sample types and the control; a slight
decrease of cell number was instead observed for Saos-2 cells seeded on the sponge-replicated coating
compared to the control.
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As a limitation to this study, cell adhesion tests were conducted in 12-well plates. Each well had a
surface area of 3.8 cm2, with a 22 mm diameter. In the control group, cells were seeded into the well
without any material and thus had a broader surface to grow. On the contrary, for the experimental
groups, cells were seeded directly on top of the tested material that was placed in the center of the well.
Since the tested materials only had a 8.6 mm diameter, the surface area of tested material was lower
than that of the well. MSCs and Saos-2 cells proliferated on both material types, but the proliferation
rates were not statistically significantly higher than the control group due to the presence of the
material itself. Another limiting factor could be related to the release of alkaline ions from the materials
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during the proliferation study. This may have changed the pH of the environment towards alkalinity
and, thus, could have caused slight differences in cell proliferation rates.
Mineralization tests, reported in Figure 6, suggest that the different coating morphologies
(foam-like vs. laser-cladded) could play a role in promoting the calcium nodule formation by MSCs,
which is a first index of cell differentiation towards osteoblastic lineage. It can be observed that the
mineralization ability of the cells grown on sponge-replicated coatings at 10 days is higher compared
to laser-cladded samples. This effect can be explained considering that the foam-derived coatings are
more porous and have a higher specific surface area available for ion-exchange phenomena compared
to the laser-cladded type (see the different morphologies reported in Figure 2). In this regard, the ionic
species released from bioactive glasses were demonstrated to stimulate cell differentiation, as well as
the genes of cells towards paths of osteogenesis and self-repair [36]. Ion leaching tests could be carried
out in future studies to further elucidate these aspects.
Int. J. Mol. Sci. 2018, 19, x 7 of 14 
 
to laser-cladded samples. This effect can be explained considering that the foam-derived coatings are 
more porous and have a higher specific surface area available for ion-exchange phenomena 
compared to the laser-cladded type (see the different morphologies reported in Figure 2). In this 
regard, the ionic species released from bioactive glasses were demonstrated to stimulate cell 
differentiation, as well as the genes of cells towards paths of osteogenesis and self-repair [36]. Ion 
leaching tests could be carried out in future studies to further elucidate these aspects. 
 
Figure 6. Mineralization test on S50B2-coated samples carried out by using MSCs (p < 0.05). 
Figure 7 shows that MSCs appear closely attached to the surface of the S50B2 coating. Cells 
exhibit a flattened morphology, with a lot of filopodia and lamellipodia. The flat and extended cell 
morphology confirms the viability of MSCs seeded on the coatings. The presence of calcium nodule 
agglomerates can also be seen, in accordance with the mineralization test results. 
 
Figure 7. SEM images of MSCs after 10 days of incubation on S50B2 scaffolds: (a) magnification at 
500× and (b) magnification at 1000×. The white arrows in (b) indicate calcium nodules. 
3. Materials and Methods 
3.1. Preparation of the Alumina/Zirconia Composite Substrates 
The raw material chosen for producing the ceramic substrates was a composite powder consisting 
of alumina and zirconia in a 75:25 (wt%) ratio. The raw powder aggregate was compressed in a 
hydrostatic press brake for obtaining cylindrical preforms, which exhibited a very fragile and brittle 
behavior. Therefore, a pre-sintering process was undertaken in order to let the samples achieve the 
necessary hardness and cohesion properties to be machined. The pre-sintering process consisted of heat 
treatment in an oven with forced air circulation with two temperature-targeted steps. The first step was 
a stop at 100 °C for 2 h to evaporate the humidity traces that could have been residing in the cylinders. 
Figure 6. Mineralization test on S50B2-coated samples carried out by using MSCs (p < 0.05).
Figure 7 shows that MSCs appear closely attached to the surface of the S50B2 coating. Cells exhibit
a flattened morphology, with a lot of filopodia and lamellipodia. The flat and extended cell morphology
confirms the viability of MSCs seeded on the coatings. The presence of calcium nodule agglomerates
can also be seen, in accordance with the mineralization test results.
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3. Materials and Methods
3.1. Preparation of the Alumina/Zirconia Composite Substrates
The raw material chosen for producing the ceramic substrates was a composite powder consisting
of alumina and zirconia in a 75:25 (wt%) ratio. The raw powder aggregate was compressed in a
hydrostatic press brake for obtaining cylindrical preforms, which exhibited a very fragile and brittle
behavior. Therefore, a pre-sintering process was undertaken in order to let the samples achieve the
necessary hardness and cohesion properties to be machined. The pre-sintering process consisted of
heat treatment in an oven with forced air circulation with two temperature-targeted steps. The first
step was a stop at 100 ◦C for 2 h to evaporate the humidity traces that could have been residing in
the cylinders. The second step was a stop at 1200 ◦C for 2 h, allowing minimum consolidation of the
geometry. After that, the cylinders were stabilized and allowed to cool down to room temperature,
thus becoming the “green” ceramic cylinders. The total time of the heat curve was 17 h, requiring 9 h
to meet the second-step target temperature with a low heating rate and the remaining 6 h to cool down.
Then, the green ceramic cylinders were subjected to special turning tooling, developed on purpose
for this application and processed in a multitasking center (Mori Seiki NT3150 DCG, 7-axis) [37].
The turning operations allowed several tens of pellet to be achieved with the desired geometry (small
disks, see Figure 8).
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Figure 8. Preparation of the composite alumina/zirconia pellets: (a) Green cylinder subjected to a
turning tooling; (b) turning operati n for obta ing the pellets; (c) disk-shaped sample o tained.
Following this, the main sintering process was undertaken. It consisted of heat treatment in an
oven with forced air circulation with a single stop at 1600 ◦C for 2 h. The total time of the heat curve
was 19 h, requiring 11 h to meet the target temperature with low-slope heating and the remaining 6 h
to cool down. During the preliminary sintering tests, a contraction factor of about 30% was observed
in the external dimensions of the pellets. This phenomenon has to be taken into account to include a
surplus factor in the turning operation so as to correctly achieve the nominal diameter. The samples
used had dimensions of a 8.6 mm diameter and a 3 mm thickness.
3.2. Preparation of the Glasses
Two glass formulations (Table 1) were selected to produce multi-layered coatings on the
alumina/zirconia composite substrates. The rationale behind the design of these glass compositions
and the relevant characterization results are described elsewhere [32]. Both glasses were produced by
using a standard melting method in a platinum crucible. The raw precursors (high-purity powders
purchased from Sigma-Aldrich, St. Louis, MO, USA; see Table 1) were homogeneously mixed in the
crucible and melted at 1450 ◦C for 1 h in air. The melt was then quenched in distilled water to produce
a frit that was ball milled (Pulverisette 6, Frtisch, Germany) and sieved either below 32 µm or within
60–150 µm by stainless steel sieves (Giuliani Technologies Srl, Torino, Italy) for further processing.
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Table 1. Composition of the starting glasses (moL.%).
Glass Code SiO2 CaO Na2O Al2O3 P2O5 B2O3 Reagents
S57A7 57 30 6 7 - - SiO2, CaCO3, Na2CO3, Al2O3
S50B2 50 35 7 - 6 2 SiO2, CaCO3, Na2CO3, Ca3(PO4)2, H3BO3
3.3. Fabrication of the Coatings
Two kinds of manufacturing processes were used to fabricate the glass coatings, i.e., (i) a proper
combination of enameling and sponge replication, or (ii) laser cladding.
3.3.1. Method 1: Enameling and Sponge Replication
The fabrication method based on enameling and sponge replication can be divided into four
stages; the first three stages are also illustrated in Figure 9.
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• Stage 1
S57A7 “green” dense coating (interlayer) was prepared on the alumina/zirconia composite
pellet by gravity-guided deposition of glass particles (<32 µm) suspended in ultrapure ethanol via
sonication. After ethanol removal, the green coating was thermally-treated at 1000 ◦C for 1 h (heating
rate 5 ◦C/min) to allow their consolidation (sintering of glass particles and adhesion of the coating
to the substrate). The presence of this (inter)layer is crucial to maximizing the adhesion between the
ceramic substrate and the top porous coating, as described in [16].
• Stage 2
A commercial open-cell polyurethane sponge (apparent density 20 kg/m−3) was manually cut
into 5-mm thick strips, from which small disks were obtained by using a metallic punch. These porous
polyurethane blocks were dipped into a water-based slurry containing S50B2 particles (<32 µm) and
polyvinyl alcohol (PVA) used as a binder (glass/PVA/water = 40:6:54 (wt%)). Each sponge disk
was soaked in the glass suspension for 60 s, extracted from it, and then axially compressed (60% of
the height) to squeeze the excess slurry out of the foam pores. Compression was performed three
times, alternating the face put in contact with the piston in order to homogeneously remove the slurry.
This sequence of actions was repeated three times, followed by a final cycle of dipping into the glass
suspension without any compression. It is noteworthy that the alumina/zirconia ceramic substrates
had a nominal diameter of 8.60 mm, but the sponge to stack on them (Stage 3 in Figure 9) had to be
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properly oversized (the punch diameter was 10.0 mm) for taking into account the volumetric shrinkage
that occurs during sintering.
• Stage 3
The S50B2-impregnated sponge (prepared in the Stage 2) was stacked onto the S57A7 glass-coated
pellet prepared in Stage 1.
• Stage 4
The three-layer system was thermally treated in an electrically-heated furnace at 1100 ◦C for 1 h
(heating rate 5 ◦C/min) in air to allow the burning-out of the polymeric sponge and the sintering of the
glass powders. As a result, the three layers were joined together and a positive glass-derived replica of
the porous polymeric template was obtained on the top.
3.3.2. Method 2: Laser Cladding
Manufacturing of dense S57A7 glass coatings (interlayer) by laser cladding involves spraying
of the glass powder over the bioceramic surface and the simultaneous action of a laser beam that
melts the particles together (Figure 10). Before reaching the target substrate, glass particles are ejected
through a narrow nozzle and, thus, there is the risk of nozzle blocking as they tend to spontaneously
agglomerate. In order to avoid that, the particles were kept in an oven at 100 ◦C for 6 h to remove
humidity prior to being used. Additionally, the powder feeder was kept at 90 ◦C during the entire
processing time in order to avoid moisture-related problems.
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The laser source was an ROFIN CO2 laser DC035 operating in the infrared region (wavelength
10.6 µm). In the present work, the pulse frequency was set at a target of 5 kHz, with a maximum power
of 350 W (thus, the duty cycle varied from 20 to 35%). In order to avoid directional heterogeneity
during the sample’s processing, the laser beam polarization was transformed from linear to circular by
means of a Cu mirror.
The powder feeder utilized (Medicoat) can introduce particles into the interaction zone by the
means of a stream of a protective inert gas (argon). For the samples required, the feeder was filled
with the S57A7 powder sieved within 90–150 µm. The powder nozzle utilized (coaxial nozzle COAX
8, Fraunhofer IWS) worked attached to the laser processing optics. The laser beam was focused to
a spot of 200 µm by a parabolic Cu mirror. The glass particles were sprayed during the operation
of the system in a coaxial direction to the laser beam. In this way, both the beam and glass reached
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the substrate at the same incidence point. During the samples’ preparation, the values chosen for the
working parameters ranged between 2 and 3 g/min for the glass mass flow and 3 L/min for the argon
volumetric carrier flow from the feeder to the nozzle and 10 L/min for the argon volumetric flow for
the shielding gas during the feeding.
The manipulation of the operation head—including both the laser optics and the powder nozzle
set- was performed in an integrated manner with the handling of the working platform—ceramic
substrate to be coated- by means of a five-axis CNC machine architecture (Lantec). This configuration
made it possible to generate laser-cladded glass tracks on any of the visible surfaces of the ceramic
pellets, and so to obtain dense coatings by overlapping several of those tracks. Laser cladding was also
experimented with to fabricate porous glass coatings over the previously-deposited dense interlayer.
The experimental setup was similar to that used to prepare the dense coating, except for the glass
powder spraying, which was replaced by the manual deposition of a high-solid-load slurry with 4 wt%
of PVA as a binder. The porosity was then created as a result of inter-particle voids left behind by water
evaporation (during post-deposition drying) and PVA burn-off due to laser scanning. The procedure
adopted here was analogous to that applied to curve surfaces in a previous work [24].
3.4. In Vitro Bioactivity
The samples were soaked in simulated body fluid (SBF) for seven days to assess their
apatite-forming ability (i.e., bioactivity). Static experiments were carried out by immersing each
specimen in 30 mL of SBF prepared according to the Kikubo’s protocol [26] and maintained at 37 ◦C
(body temperature). The solution was refreshed twice a week to simulate fluid circulation as it occurs
in the human body. At the end of the experiment, the samples were gently rinsed with distilled
water and left to dry at room temperature, before being studied by scanning electron microscopy
(SEM; SupraTM 40, Zeiss, Oberkochen, Germany) incorporating Energy Dispersive Spectroscopy (EDS).
The sample surface was sputter-coated with chromium prior to the SEM-EDS analysis.
Before being assessed by means of SEM-EDS, several samples were prepared in a matrix of epoxy
resin (Struers Epofix), cut by a diamond wheel (Struers Accutom 5) and polished using SiC grit papers
#600 to #4000 (PACE Technologies, Tucson, AZ, USA).
3.5. Biological Tests
Both types of coatings underwent in vitro biological assessment to evaluate cell adhesion,
proliferation, and mineralization ability.
3.5.1. Cell Isolation, Expansion, and Culture
Bone Marrow (BM) Mononuclear Cells (MNC) (Lonza Group, Basel, C.H.) were isolated by
density centrifugation with Ficoll hypaque (1.077 g/L; Biochrom AG, Berlin, Germany). Cell culture
medium consisted of low-glucose Dulbecco’s modified Eagle medium (LG-DMEM; Biochrom AG,
Berlin, Germany), along with 10% fetal calf serum (FCS; Biochrom AG, Berlin, Germany) and 1%
penicillin/streptomycin (Biochrom AG, Berlin, Germany). The complete medium was replaced every
three to four days. Cells were harvested with 0.25% trypsin/1 mm EDTA and re-plated when adherent
cells reached sub-confluence. From passage 3 (P3), mesenchymal stem cells (MSCs) were characterized
according to the positive expression of CD 90, CD 105, CD 73, CD 44, and CD 49e surface markers
with a FACSAria flow cytometer (Becton Dickinson, Franklin Lakes, N.J., USA). Primary human
osteosarcoma cell line Saos-2 was purchased from Sigma-Aldrich (Sigma Aldrich, St. Louis, MO, USA).
3.5.2. Adhesion Test
Total 308000 MSCs and 308000 SaOS-2 cells were used. Adhesion assays were carried out on
days 3 and 7. Control groups were MSCs and Saos type 2 cells cultured in the appropriate medium
without samples. Tests were carried out in triplicate for each material and cell group. The cells were
cultured with MSC or SaOS-2 medium, according to cell type. MSC culture medium consisted of
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52.8% Dulbecco’s Modified Eagle Medium (DMEM) with 1 g/L glucose (Lonza, Basel, Switzerland),
35.2% MCDB-201 medium (Sigma Aldrich, St. Louis, MO, USA), 10% heat inactivated fetal bovine
serum (FBS) (Sigma Aldrich, St. Louis, MO, USA), 1% penicillin/streptomycin solution (Biochrom AG,
Berlin, Germany), and 1% L-glutamine (Biochrom AG, Berlin, Germany), while SaOS-2 culture medium
consisted of 89% DMEM with 4.5 g/L glucose (Sigma Aldrich), 10% heat inactivated FBS, and 1%
penicillin/streptomycin solution. Every three to four days, the medium was replaced. The plates were
incubated at 37 ◦C with relative humidity under an atmosphere of 5% CO2. On the third and seventh
days, the wells were washed with PBS (Oxoid, Hampshire, United Kingdom) and 1 mL Trypsin/EDTA
(Thermo Fisher, Waltham, MA, USA) was applied. A 50 µL cell suspension was mixed with 50 µL
Trypan blue (Biological Industries, Beit HaEmek, Israel) in a centrifuge tube and the cells were counted
on Thoma lamina.
3.5.3. SEM Investigation
Then, 40,000 MSCs were cultured on the glass-coated ceramic pellets. The cells were incubated
with samples and growth medium (DMF10) composed of 10% fetal bovine serum (FBS) (Invitrogen,
Carlsbad, CA, USA), 1% penicillin-streptomycin (Biochrom AG, Berlin, Germany), and DMEM-LG
(Biological Industries, Beit HaEmek, Israel) containing 1% L-glutamine (Biochrom AG, Berlin, Germany)
in six-well plates. On the third day, medium was removed from the wells and samples were washed
with PBS two times. After that, 3 mL 2.5% glutaraldehyde (Merck, Darmstadt, Germany) in distilled
water was added to the wells and left for 30 min. Then, the cells were again washed with PBS
and thereafter were dehydrated with graded ethanol series in distilled water. The samples were
incubated in 50% EtOH (5 min), 70% EtOH (5 min), 80% EtOH (10 min), 95% EtOH (10 min), and 100%
EtOH (20 min). Air-dried samples were prepared for SEM analysis by sputter-coating with gold.
The gold-coated samples were analyzed by a JEOL scanning electron microscope JSM 6400 (Jeol Ltd.,
Akishima, Japan).
3.5.4. Mineralization Assays
In total, 375000 MSCs were used. Time points for the assay were day 10 and 21. The control group
was blank MSCs incubated in the medium without samples. The cells were incubated with samples and
growth medium in 12-well plates for the first day. Every three to four days, the medium was replaced.
When the cells reached 50–60% confluence, differentiation medium containing DMEM-LG, 10% FBS,
100 nmol/L dexamethasone (Sigma-Aldrich, St. Louis, MO, USA), 10 mmol/L beta glycerophosphate
(Sigma-Aldrich, St. Louis, MO, USA), and 0.2 mmol/L ascorbic acid (Sigma- Aldrich, St. Louis,
MO, USA) was added to the wells. On the tenth and twenty-first days, wells were analyzed by
the Quantichrom Calcium Assay Kit (Bio Assay Systems, Hayward, CA, USA), according to the
manufacturer’s instructions.
3.5.5. Statistics
Results are expressed as the mean ± SD. Statistical differences among the groups were analyzed
by Tukey’s multiple comparison test (p < 0.05).
4. Conclusions
This study provides early evidence of the bioactive properties and biocompatibility of innovative
porous glass coatings for potential use in hip joint prosthesis applications. The trabecular glass coatings,
intended to be in contact with the host bone once implanted in vivo, exhibit a clear HA-forming ability
in vitro, which can be considered as a precondition for bonding to bone in the body. No problems of
interfacial delamination were assessed at the end of in vitro experiments. The good biological behavior
of the coatings was assessed by the proliferation of mesenchymal and osteoblast-like cells, associated
with the increasing synthesis of calcium nodules over time compared to uncoated ceramic substrates.
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BO Bridging Oxygen
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CM Confocal Microscopy
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